Answers are grounded in this paper and cite their sources.
Randomized controlled trial demonstrates short-term pain relief and reduced Raynaud's duration in systemic sclerosis, suggesting further investigation is needed.
Adjunctive wIRA during iloprost therapy was safe and yielded modest, short-term improvements in pain and RP duration. These exploratory effects warrant confirmation in larger controlled trials.
No takes yet. Share an insight, caveat, or question.
Schulz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: